Literature DB >> 26045476

Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs.

Juan José Alburquerque-Béjar1, Ignasi Barba1, Javier Inserte1, Elisabet Miró-Casas1, Marisol Ruiz-Meana1, Marcos Poncelas1, Úrsula Vilardosa1, Laura Valls-Lacalle1, Antonio Rodríguez-Sinovas2, David Garcia-Dorado2.   

Abstract

AIMS: Remote ischaemic conditioning (RIC) has been shown to reduce myocardial infarct size in patients. Our objective was to investigate whether the combination of RIC with either exenatide or glucose-insulin-potassium (GIK) is more effective than RIC alone. METHODS AND
RESULTS: Pigs were submitted to 40 min of coronary occlusion followed by reperfusion, and received (i) no treatment, (ii) one of the following treatments: RIC (5 min ischemia/5 min reperfusion × 4), GIK, or exenatide (at doses reducing infarct size in clinical trials), or (iii) a combination of two of these treatments (RIC + GIK or RIC + exenatide). After 5 min of reperfusion (n = 4/group), prominent phosphorylation of Akt and endothelial nitric oxide synthase (eNOS) was observed, both in control and reperfused myocardium, in animals receiving GIK, and mitochondria from these hearts showed reduced ADP-stimulated respiration. (1)H NMR-based metabonomics disclosed a shift towards increased glycolysis in GIK and exenatide groups. In contrast, oxidative stress (myocardial nitrotyrosine levels) and eNOS uncoupling were significantly reduced only by RIC. In additional experiments (n = 7-10/group), ANOVA demonstrated a significant effect of the number of treatments after 2 h of reperfusion on infarct size (triphenyltetrazolium, % of the area at risk; 59.21 ± 3.34, 36.64 ± 3.03, and 21.04 ± 2.38% for none, one, and two treatments, respectively), and significant differences between one and two treatments (P = 0.004) but not among individual treatments or between RIC + GIK and RIC + exenatide.
CONCLUSIONS: GIK and exenatide activate cardioprotective pathways different from those of RIC, and have additive effects with RIC on infarct size reduction in pigs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  GLP-1; Insulin; Myocardial infarction; Remote ischaemic conditioning; Reperfusion injury

Mesh:

Substances:

Year:  2015        PMID: 26045476     DOI: 10.1093/cvr/cvv171

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

Review 1.  Myocardial remote ischemic preconditioning: from cell biology to clinical application.

Authors:  Martín Donato; Ricardo J Gelpi; Eliana P Bin; Verónica D Annunzio
Journal:  Mol Cell Biochem       Date:  2021-06-14       Impact factor: 3.396

2.  Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats.

Authors:  Songyi Cheng; Peng Yu; Li Yang; Haibo Shi; Anxia He; Hanyu Chen; Jie Han; Liang Xie; Jiandong Chen; Xiaohu Chen
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI).

Authors:  Bruno García Del Blanco; Imanol Otaegui; José F Rodríguez-Palomares; Antoni Bayés-Genis; Eduard Fernández-Nofrerías; Victoria Vilalta Del Olmo; Xavier Carrillo; Borja Ibáñez; Fernando Worner; Juan Casanova; Eva Pueo; Jose R González-Juanatey; Javier López-Pais; Alfredo Bardají; Gil Bonet; Mónica Fuertes; Antonio Rodríguez-Sinovas; Marisol Ruiz-Meana; Javier Inserte; Ignasi Barba; Sandra Gómez-Talavera; Gerard Martí; Bernat Serra; Neus Bellera; Manuel Ojeda-Ramos; Hug Cuellar; Filipa Valente; Maria Ángeles Carmona; Elisabet Miró-Casas; Josep R Marsal; Antonia Sambola; Rosa M Lidón; Jordi Bañeras; Jaime Elízaga; Ferran Padilla; José A Barrabés; Derek J Hausenloy; Ignacio Ferreira-González; David García-Dorado
Journal:  Basic Res Cardiol       Date:  2021-01-25       Impact factor: 17.165

4.  Searching myocardial rescue through intermittent upper arm occlusion and lizard saliva.

Authors:  Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-01-25       Impact factor: 17.165

5.  Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size.

Authors:  Laura Valls-Lacalle; Ignasi Barba; Elisabet Miró-Casas; Marisol Ruiz-Meana; Antonio Rodríguez-Sinovas; David García-Dorado
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

Review 6.  Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis.

Authors:  Daniel I Bromage; Jack M J Pickard; Xavier Rossello; Oliver J Ziff; Niall Burke; Derek M Yellon; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

Review 7.  Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.

Authors:  Derek J Hausenloy; Hans Erik Bøtker; Peter Ferdinandy; Gerd Heusch; G André Ng; Andrew Redington; David Garcia-Dorado
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

8.  Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside.

Authors:  Hector A Cabrera-Fuentes; Corina Alba-Alba; Julian Aragones; Jürgen Bernhagen; William A Boisvert; Hans E Bøtker; Gabriela Cesarman-Maus; Ingrid Fleming; David Garcia-Dorado; Sandrine Lecour; Elisa Liehn; Michael S Marber; Nephtali Marina; Manuel Mayr; Oscar Perez-Mendez; Tetsuji Miura; Marisol Ruiz-Meana; Eduardo M Salinas-Estefanon; Sang-Bing Ong; Hans J Schnittler; Jose T Sanchez-Vega; Adriana Sumoza-Toledo; Carl-Wilhelm Vogel; Dina Yarullina; Derek M Yellon; Klaus T Preissner; Derek J Hausenloy
Journal:  Basic Res Cardiol       Date:  2015-12-14       Impact factor: 17.165

9.  Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning.

Authors:  Tamás Baranyai; Csilla Terézia Nagy; Gábor Koncsos; Zsófia Onódi; Melinda Károlyi-Szabó; András Makkos; Zoltán V Varga; Péter Ferdinandy; Zoltán Giricz
Journal:  Cardiovasc Diabetol       Date:  2015-11-18       Impact factor: 9.951

Review 10.  Reducing myocardial infarct size: challenges and future opportunities.

Authors:  Heerajnarain Bulluck; Derek M Yellon; Derek J Hausenloy
Journal:  Heart       Date:  2015-12-16       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.